Spots Global Cancer Trial Database for osteoporosis
Every month we try and update this database with for osteoporosis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Evaluation of Outcomes for Quality of Life and Activities of Daily Living for BKP in the Treatment of VCFs | NCT01871519 | Compression Fra... Osteoporosis Cancer | Balloon kyphopl... | 65 Years - | Medtronic Spinal and Biologics | |
Sarcopenia and Risk of Falls in Patients With Major Chronic Diseases | NCT03798418 | Stroke Osteoporosis Chronic Kidney ... Cancer | elastic band st... diet counseling | - | Changhua Christian Hospital | |
Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast Density | NCT00114270 | Breast Cancer Osteoporosis | letrozole zoledronic acid | 18 Years - | National Cancer Institute (NCI) | |
Guangzhou Nutrition and Health Study (GNHS) | NCT03179657 | Cardiovascular ... Osteoporosis Diabetes Mellit... Metabolic Syndr... Obesity Hypertension Non-Alcoholic F... Chronic Kidney ... Cancer Death Nutrition Disor... Sarcopenia | 40 Years - 83 Years | Sun Yat-sen University | ||
A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis | NCT05775094 | Multiple Myelom... Osteoporosis | Romosozumab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Evaluation of PET/MR and PET/CT Imaging for Bone Marrow Lesions | NCT01880762 | Multiple Myelom... Disease of the ... Osteoporosis | 30 Years - 80 Years | NYU Langone Health | ||
One Week Comparison Study of PTH and PTHrP Infusions | NCT01333267 | Osteoporosis Hypercalcemia o... Hyperparathyroi... Bone Diseases, ... | Parathyroid Hor... parathyroid hor... PTH (1-34) and ... | 24 Years - 35 Years | University of Pittsburgh | |
Longitudinal Study of Bone Mineral Density in Survivors of Solid Pediatric Cancers | NCT00615485 | Osteoporosis | 7 Years - 40 Years | State University of New York - Upstate Medical University | ||
PatientSpot Formerly Known as ArthritisPower | NCT03840928 | Rheumatoid Arth... Ankylosing Spon... Fibromyalgia Gout Crohn Disease Juvenile Idiopa... Lupus Erythemat... Myositis Osteoarthritis Osteoporosis Psoriasis Psoriatic Arthr... Scleroderma Dermatomyositis Inflammatory Bo... Polymyositis Axial Spondyloa... Diffuse Idiopat... Polymyalgia Rhe... Giant Cell Arte... Temporal Arteri... Wegener Relapsing Polyc... Undifferentiate... Spinal Cord Inj... Alzheimer Disea... Amyotrophic Lat... Ataxia Bell Palsy Brain Tumor Cerebral Aneury... Epilepsy Guillain-Barre ... Headache Head Injury Hydrocephalus Lumbar Disc Dis... Meningitis Multiple Sclero... Muscular Dystro... Neurocutaneous ... Parkinson Disea... Stroke Cluster Headach... Tension-Type He... Chronic Obstruc... Asthma Lung Cancer Cystic Fibrosis Sleep Apnea Eczema Alopecia Chronic Inflamm... Unstable Angina Heart Attack Heart Failure Arrythmia Valve Heart Dis... High Blood Pres... Congenital Hear... Peripheral Arte... Diabetes Chronic Liver D... Obesity | 19 Years - | Global Healthy Living Foundation | ||
Exercise for Physical Health in Men With Prostate Cancer | NCT00660686 | Prostatic Neopl... Osteoporosis | Resistance Exer... Flexibility Tra... | 18 Years - 100 Years | OHSU Knight Cancer Institute | |
Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer | NCT00587925 | Breast Cancer Osteoporosis | Bone Mineral De... | - | Memorial Sloan Kettering Cancer Center | |
Osteoporosis Among Men Treated With Androgen Deprivation for Prostate Cancer | NCT00957606 | Prostate Cancer Androgen Depriv... Osteoporosis | blood sampling,... | - | Odense University Hospital | |
Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer | NCT00176579 | Osteoporosis Prostate Cancer | dual x-ray abso... | 50 Years - 75 Years | Rutgers, The State University of New Jersey | |
An Open Label Non-Interventional Evaluation of the Effect of Adjuvant Hormonal Treatment of Postmenopausal Women Wih Early Breast Cancer With Aromatase Inhibitors on Bone Mineral Density and Bone Fracture Rate in Daily Practice | NCT00767585 | Breast Cancer Osteoporosis | 55 Years - 65 Years | AstraZeneca | ||
Swedish Mammography Cohort | NCT01127698 | Cancers Cardiovascular ... Cataract Gastrointestina... Osteoporosis Fractures | 40 Years - 74 Years | Karolinska Institutet | ||
One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study | NCT00580788 | Osteoporosis Humoral Hyperca... Hyperparathyroi... | PTHrP (1-36) | 24 Years - 35 Years | University of Pittsburgh | |
Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02 | NCT00963417 | Breast Cancer Osteoporosis | laboratory biom... dual x-ray abso... | 18 Years - 120 Years | ETOP IBCSG Partners Foundation | |
Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer | NCT00031811 | Breast Cancer Menopausal Symp... Osteoporosis | raloxifene quality-of-life... | - | OHSU Knight Cancer Institute | |
Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98 | NCT00369850 | Breast Cancer Osteoporosis | laboratory biom... Dual energy X-r... Spine X-ray | 30 Years - | ETOP IBCSG Partners Foundation | |
Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast Cancer | NCT00436917 | Breast Cancer Osteoporosis | zoledronic acid Letrozole as ad... | 18 Years - 120 Years | Mayo Clinic | |
Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study | NCT02632903 | Osteoporosis Osteonecrosis Acute Lymphobla... | Zoledronic acid | 8 Years - 16 Years | Children's Hospital of Eastern Ontario | |
The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy | NCT00063609 | Prostate Cancer | zoledronic acid | 18 Years - | Novartis | |
Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer | NCT00022087 | Breast Cancer Osteoporosis | calcium salts cholecalciferol zoledronic acid | 40 Years - | Alliance for Clinical Trials in Oncology | |
Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma | NCT00301873 | Brain Tumors Osteoporosis Central Nervous... | IV Zometa | 18 Years - | Duke University | |
Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer | NCT00859703 | Breast Cancer Menopause Osteopenia | Risedronate Placebo | 18 Years - | Hospices Civils de Lyon | |
Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer | NCT00049452 | Breast Cancer Osteoporosis | zoledronic acid | 18 Years - 50 Years | National Cancer Institute (NCI) | |
Bone Microstructure by Using HR-pQCT After Esophagectomy | NCT05812235 | Osteoporosis Sarcopenia Esophageal Canc... | esophagectomy | 50 Years - 90 Years | Nagasaki University | |
99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis | NCT02304757 | Differentiated ... Osteoporosis | 99Tc-MDP Fosamax | 45 Years - | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | |
The Bone-parathyroid Crosstalk in Primary Hyperparathyroidism | NCT05556499 | Hyperparathyroi... Osteoporosis Parathyroid Neo... | Biomarker assay... | 18 Years - | I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio | |
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer | NCT00043069 | Osteoporosis Prostate Cancer | calcium carbona... cholecalciferol Estrogen Antago... risedronate sod... placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
Impact of Allo-HSCT on Bone Remodeling: Evolution of Bone Mineral Density and Architecture Measured by Bone Densitometry | NCT05161026 | Myeloid Leukemi... | Bone osteodensi... | 18 Years - 75 Years | University Hospital, Caen | |
Outcome of Dental Implant Therapy in Patients Treated With Antiresorptive Medication | NCT04741906 | Missing Teeth Implants Cancer Osteoporosis | Dental implant ... Prosthetic trea... | - | Copenhagen University Hospital at Herlev | |
Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption? | NCT00766532 | Breast Cancer Osteoporosis Osteopenia Fracture | Aromatase Inhib... | - | University of Wisconsin, Madison | |
Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast Cancer | NCT00436917 | Breast Cancer Osteoporosis | zoledronic acid Letrozole as ad... | 18 Years - 120 Years | Mayo Clinic | |
Cohort of Swedish Men | NCT01127711 | Cancers Cardiovascular ... Cataract Gastrointestina... Osteoporosis Fractures | 45 Years - 79 Years | Karolinska Institutet | ||
A Study of High-Dose Vit D Versus Standard of Care Vit D Supplementation | NCT05016310 | Breast Breast Cancer Osteoporosis | High Dose Vitam... Standard of Car... | 18 Years - 45 Years | Wake Forest University Health Sciences | |
Exercise for Physical Health in Men With Prostate Cancer | NCT00660686 | Prostatic Neopl... Osteoporosis | Resistance Exer... Flexibility Tra... | 18 Years - 100 Years | OHSU Knight Cancer Institute | |
Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study | NCT02632903 | Osteoporosis Osteonecrosis Acute Lymphobla... | Zoledronic acid | 8 Years - 16 Years | Children's Hospital of Eastern Ontario | |
Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98 | NCT00369850 | Breast Cancer Osteoporosis | laboratory biom... Dual energy X-r... Spine X-ray | 30 Years - | ETOP IBCSG Partners Foundation | |
Myeloproliferative Neoplasms and Bone Structure | NCT01816022 | Polycythemia Ve... Thrombocythemia... Primary Myelofi... | 18 Years - | University of Southern Denmark | ||
OsseoScrew Versus Fenestrated Pedicle Screws Augmented With Polymethylmethacrylate | NCT01613144 | Osteoporosis Poor Bone Quali... | OsseoScrew Spin... | 18 Years - | Alphatec Spine, Inc. | |
Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-Effects | NCT00497458 | Breast Cancer Arthralgia Osteoporosis | Testosterone | 18 Years - 85 Years | Havah Therapeutics Pty Ltd | |
Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation | NCT00058188 | Osteoporosis Prostate Cancer | cholecalciferol calcium glucona... zoledronic acid | 18 Years - | Northwestern University | |
Women's Health Initiative (WHI) | NCT00000611 | Bone Diseases Breast Neoplasm... Cardiovascular ... Colonic Neoplas... Coronary Diseas... Heart Diseases Myocardial Isch... Osteoporosis Postmenopause | hormone replace... estrogens progestins estrogen replac... diet, fat-restr... calcium vitamin D dietary supplem... | 50 Years - 79 Years | National Heart, Lung, and Blood Institute (NHLBI) | |
A Natural History Study of Bone and Mineral Disorders | NCT00024804 | Tumor Induced O... Osteomalacia Familial Tumora... | 1 Day - | National Institutes of Health Clinical Center (CC) | ||
One Week Comparison Study of PTH and PTHrP Infusions | NCT01333267 | Osteoporosis Hypercalcemia o... Hyperparathyroi... Bone Diseases, ... | Parathyroid Hor... parathyroid hor... PTH (1-34) and ... | 24 Years - 35 Years | University of Pittsburgh | |
Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer | NCT00079248 | Breast Cancer Hot Flashes Menopausal Symp... Osteoporosis | therapeutic pro... conjugated estr... | - | National Cancer Institute (NCI) | |
Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-Effects | NCT00497458 | Breast Cancer Arthralgia Osteoporosis | Testosterone | 18 Years - 85 Years | Havah Therapeutics Pty Ltd | |
The Bone-parathyroid Crosstalk in Primary Hyperparathyroidism | NCT05556499 | Hyperparathyroi... Osteoporosis Parathyroid Neo... | Biomarker assay... | 18 Years - | I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio | |
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer | NCT00054418 | Breast Cancer Osteoporosis | calcium carbona... vitamin D risedronate sod... placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
Prospective Study of Patients With Rheumatoid Arthritis After the Age of 65 | NCT02686320 | Rheumatoid Arth... | 18 Years - | Assistance Publique - Hôpitaux de Paris | ||
Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss | NCT00925600 | Cancer Cataract Low Bone Minera... Osteopenia Osteoporosis Prostate Cancer | Denosumab Placebo | 30 Years - 120 Years | Amgen | |
Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer | NCT00859703 | Breast Cancer Menopause Osteopenia | Risedronate Placebo | 18 Years - | Hospices Civils de Lyon | |
Multi-centre Clinical Trial on Hormone Replacement Treatment in China | NCT01698164 | Menopausal Synd... Cardiovascular ... Osteoporosis Breast Cancer | estradiol plus ... Ximingting Tabl... estradiol plus ... | 40 Years - 60 Years | Peking Union Medical College Hospital | |
Danish Osteoporosis Prevention Study | NCT00252408 | Osteoporosis | Hormone replace... | 45 Years - 58 Years | University of Aarhus | |
Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer Survivors | NCT04472286 | Acute Lymphobla... Pediatric ALL Pediatric Lymph... Bone Loss Metabolic Syndr... Habitual Physic... Precursor Cell ... Lymphoma Leukemia Lymphoid Leukem... Pediatric Osteoporosis Osteoporosis Ri... | 5 Years - 18 Years | University of Nebraska | ||
Women's Use of Alternative Medicine: A Multiethnic Study | NCT00067249 | Uterine Fibroid... Osteoporosis Urinary Tract I... High Blood Pres... Heart Disease Arthritis Depression Headaches | 18 Years - | National Center for Complementary and Integrative Health (NCCIH) | ||
Fosamax for Childhood Cancer Survivors | NCT00391404 | Osteoporosis | Alendronate Placebo | 15 Years - | Chinese University of Hong Kong | |
Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy | NCT00129142 | Prostate Cancer Osteoporosis Fractures | Toremifene Citr... | 50 Years - | GTx | |
Breast Cancer Women on Aromatase Inhibitors Treatment | NCT03811509 | Osteoporosis Osteoporosis Fr... Arthralgia Gene... | bisphosphonate | 40 Years - 80 Years | Parc de Salut Mar | |
MoveStrong at Home: A Feasibility Study of a Model for Remote Delivery of Functional Strength and Balance Training Combined With Nutrition Education for Older Pre-frail Adults. | NCT04663685 | Arthritis Cancer Cardiovascular ... Chronic Lung Di... Congestive Hear... Diabetes Hypertension Kidney Diseases Obesity Osteoporosis Stroke Frailty | Exercise progra... Nutrition educa... | 60 Years - | University of Waterloo | |
Bicalutamide Monotherapy Has Significant Quality of Life Benefits for Men With Advanced Prostate Cancer | NCT00551044 | Prostatic Neopl... | Bicalutamide | - | Wirral University Teaching Hospital NHS Trust | |
Health and QoL in Oncological Patients: Management of Bone Pathology in Italian Citbl Population | NCT04055805 | Breast Cancer F... Osteoporosis | Observational A... | 18 Years - 75 Years | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
A Natural History Study of Bone and Mineral Disorders | NCT00024804 | Tumor Induced O... Osteomalacia Familial Tumora... | 1 Day - | National Institutes of Health Clinical Center (CC) | ||
Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3 | NCT00688246 | Breast Cancer Osteoporosis | biologic sample... dual x-ray abso... | 35 Years - | Canadian Cancer Trials Group | |
Bone Mineral Density and Subsequent Cancer Risk | NCT00340262 | Endometrial Can... Breast Cancer | 55 Years - 80 Years | National Institutes of Health Clinical Center (CC) | ||
Multi-centre Clinical Trial on Hormone Replacement Treatment in China | NCT01698164 | Menopausal Synd... Cardiovascular ... Osteoporosis Breast Cancer | estradiol plus ... Ximingting Tabl... estradiol plus ... | 40 Years - 60 Years | Peking Union Medical College Hospital | |
Screening of Bone Mineral Density in Women Who Have Received Chemotherapy | NCT00603551 | Bone Density Cancer | 18 Years - | Medical University of South Carolina | ||
Fosamax for Childhood Cancer Survivors | NCT00391404 | Osteoporosis | Alendronate Placebo | 15 Years - | Chinese University of Hong Kong | |
Fingernails in Evaluating Bone Health in Postmenopausal Women With Breast Cancer Undergoing Hormone Therapy on Clinical Trial IBCSG-1-98 | NCT00899288 | Breast Cancer Osteoporosis | spectroscopy | 30 Years - | ETOP IBCSG Partners Foundation | |
A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis | NCT05775094 | Multiple Myelom... Osteoporosis | Romosozumab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Women's Health Initiative (WHI) | NCT00000611 | Bone Diseases Breast Neoplasm... Cardiovascular ... Colonic Neoplas... Coronary Diseas... Heart Diseases Myocardial Isch... Osteoporosis Postmenopause | hormone replace... estrogens progestins estrogen replac... diet, fat-restr... calcium vitamin D dietary supplem... | 50 Years - 79 Years | National Heart, Lung, and Blood Institute (NHLBI) | |
99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis | NCT02304757 | Differentiated ... Osteoporosis | 99Tc-MDP Fosamax | 45 Years - | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | |
One Week Comparison Study of PTH and PTHrP Infusions | NCT01333267 | Osteoporosis Hypercalcemia o... Hyperparathyroi... Bone Diseases, ... | Parathyroid Hor... parathyroid hor... PTH (1-34) and ... | 24 Years - 35 Years | University of Pittsburgh | |
Outcome of Dental Implant Therapy in Patients Treated With Antiresorptive Medication | NCT04741906 | Missing Teeth Implants Cancer Osteoporosis | Dental implant ... Prosthetic trea... | - | Copenhagen University Hospital at Herlev | |
Osteoporosis in Children With ALL | NCT00330538 | Leukemia, Lymph... | 4 Years - 18 Years | Children's Mercy Hospital Kansas City | ||
A Natural History Study of Bone and Mineral Disorders | NCT00024804 | Tumor Induced O... Osteomalacia Familial Tumora... | 1 Day - | National Institutes of Health Clinical Center (CC) | ||
Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy | NCT00485953 | Bone Loss Osteoporosis Breast Cancer | risedronate | 55 Years - | University of Pittsburgh | |
Screening of Bone Mineral Density in Women Who Have Received Chemotherapy | NCT00603551 | Bone Density Cancer | 18 Years - | Medical University of South Carolina | ||
Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer | NCT00332709 | Osteoporosis Postmenopausal | Letrozole Zoledronic acid | 18 Years - | Novartis |